Ajooni Biotech Limited — Others, 17-04-2025: Disclosure under SEBI Takeover Regulations

Ajooni Biotech Limited has disclosed that neither it nor its associated parties have encumbered shares during the financial year ended March 31, 2025. This announcement could signal stability in shareholding, potentially fostering investor confidence. By confirming no encumbrance, the company aims to present a clear picture of its financial health, which may alleviate concerns over liquidity and ownership control among shareholders. Investors may view this positively, as it suggests a commitment to maintaining robust corporate governance and shareholder interests.